XML 15 R4.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2018
Dec. 31, 2017
Income Statement [Abstract]        
Revenues $ 1,510
Cost of Sales
Gross Profit 1,510
Operating Expenses:        
Sales and Marketing 1,174 28,005
Research and Development 55,916 16,659 133,789 62,818
General and Administrative:        
Depreciation and Amortization 162,590 159,735 485,331 483,317
Equity Instrument Expenses 179,987 112,143 2,117,279 251,756
Other General and Administrative 159,950 244,356 619,892 532,935
Total General and Administration 502,527 516,234 3,222,502 1,268,008
Total Operating Expenses 559,617 532,893 3,384,296 1,330,826
Operating Loss (559,617) (532,893) (3,384,296) (1,329,316)
Other Income (Expense)        
Gain on Settlement of Debt 22,000 22,000
Interest Expense (60,326) (45,675) (76,112) (71,739)
Total Other Income (Expense) (60,326) (23,675) (76,112) (49,739)
Net Loss before taxes (619,943) (556,568) (3,460,408) (1,379,055)
Income Tax Provision
Net Loss $ (619,943) $ (556,568) $ (3,460,408) $ (1,379,055)
Net Loss Per Share:        
Basic and Diluted $ (0.03) $ (0.03) $ (0.17) $ (0.08)
Weighted Average Shares Outstanding:        
Basic and Diluted 20,533,305 17,168,329 20,081,984 16,506,923